Fundamental dimension Equity attribute | AQSZFPeer $0.00030.00% Cap $39.79KP/E 3.1x QuantScore48/100 | ACUSLeader $0.000.00% Cap $50P/E -0.0x QuantScore51/100 | BIOAFPeer $0.00010.00% Cap $7.94KP/E -0.1x QuantScore23/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
43/100 |
68/100 |
51/100 |
Valuation Multiples, PEG & DCF upside | 69/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | 44/100 | 20/100 |
Growth Revenue / earnings growth & margins | 56/100 | 58/100 | 20/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 3.1x | -0.0x | -0.1x |
Forward P/E (next FY) | — | — | -0.0x |
EV / EBITDA (TTM) | 15.6x | 0.2x | -0.2x |
Price / Sales | 1.4x | 0.0x | 10.5x |
Price / Free Cash Flow | -14.1x | -0.0x | -0.1x |
PEG ratio | 0.02 | -0.00 | -0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 3 / 9 | 2 / 9 |
Altman Z-Score | -297.95 (Distress) | -30.04 (Distress) | -42.04 (Distress) |
Total debt / equity | -0.87 | 0.76 | -0.99 |
Quick ratio | 0.0x | 1.5x | 0.7x |
Interest coverage | -1.4x | 25.7x | -7.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +129.2% | +49.7% | -99.1% |
Net income growth YoY | +26.5% | +12.0% | -523.8% |
Gross margin (TTM) | 51.0% | 100.0% | -45.6% |
Operating margin (FY) | -364.1% | 1977.0% | -12784.5% |
FCF margin (FY) | -283.4% | -1601.2% | -9636.9% |
5. Trailing price performancePrice change over period |
1M return | -57.1% | 0.0% | +0.0% |
3M return | -88.5% | 0.0% | +0.0% |
6M return | -40.0% | 0.0% | +0.0% |
Year to date | -85.0% | 0.0% | -50.0% |
1Y return | -85.7% | 0.0% | -50.0% |
3Y return | -98.8% | 0.0% | -98.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0785 -26282.7% premium | $-41.82 -418177659.1% premium | $-0.0125 -12625.3% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |